Leveraging non-dilutive funding for drug discovery and development
October 2 @ 11:00 am - 12:30 pm
Eva Garland Consulting (EGC) is pleased to present a three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued commitment to providing valuable insights about the non-dilutive funding landscape to the scientific and entrepreneurial communities.
- September 18 – Harvesting America’s Seed Fund: Guidance for navigating the NSF’s SBIR / STTR application process
- October 2 – Leveraging non-dilutive funding for drug discovery and development
- October 23 – Department of Energy funding for emerging businesses
Presented by: Connie Vance, Ph. D. and Tiger Xie, Ph. D.
Non-dilutive funding, particularly from government grants and contracts, is a valuable resource for biopharmaceutical start-ups. Each year, major U.S. government agencies allocate tens of billions of dollars to small businesses to support innovative drug development initiatives.
This webinar will cover key strategies for utilizing non-dilutive funding sources to support various stages of the drug discovery and development process. It will also provide an overview of major government and private foundation funding opportunities that support the biopharma industry. Additionally, Dr. Vance and Dr. Xie will share valuable tips on how to prepare competitive grant applications specifically tailored for drug discovery and development initiatives.
